Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05784961
What this trial is testing

Impact of tDCS on Cannabis Craving in Schizophrenia

Who this might be right for
SchizophreniaCannabis Use Disorder
Centre hospitalier de Ville-Evrard, France 138
Large-scale testing (Phase 3)Study completedNCT00711269
What this trial is testing

Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma Co., Ltd. 460
Not applicableStudy completedNCT05345977
What this trial is testing

EMotiph: E-mental Health Solution for Patients With Schizophrenia

Who this might be right for
Schizophrenia
Grupo Pulso 7
Post-approval studies (Phase 4)Study completedNCT01279070
What this trial is testing

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

Who this might be right for
Indication for Modification of Patient Cognitive Status
Fundació Sant Joan de Déu 62
Not applicableLooking for participantsNCT07242586
What this trial is testing

PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)Schizotypal DisorderPost Traumatic Stress Symptoms
Nikolai Albert 20
Large-scale testing (Phase 3)Study completedNCT00250575
What this trial is testing

Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
Novartis 43
Not applicableNot Yet RecruitingNCT07154407
What this trial is testing

AI-assisted Masticatory Muscle Training in Patients With Schizophrenia

Who this might be right for
Schizophrenia Disorder
Kaohsiung Medical University Chung-Ho Memorial Hospital 100
Not applicableUnknownNCT05995457
What this trial is testing

The IM-ZBULLE Study : " Z-track " and " Airlock " Techniques During Intramuscular Injection of Haloperidol Decanoate

Who this might be right for
Schizophrenia; Psychosis
Centre Hospitalier St Anne 84
Post-approval studies (Phase 4)Study completedNCT01164059
What this trial is testing

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
University of Bremen 149
Post-approval studies (Phase 4)Study completedNCT00329810
What this trial is testing

Effect on Cognitive Function of a Treatment With Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 500
Large-scale testing (Phase 3)Study completedNCT00412373
What this trial is testing

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Who this might be right for
Schizoaffective DisorderPsychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307
Post-approval studies (Phase 4)Study completedNCT02736474
What this trial is testing

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

Who this might be right for
ObeseCigarette-smokingSchizophrenia
Shanghai Mental Health Center 22
Not applicableStudy completedNCT00283517
What this trial is testing

A Registry of Treatment Adherence for Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag, S.A. 2,046
Post-approval studies (Phase 4)Study completedNCT00325689
What this trial is testing

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Who this might be right for
SchizophreniaSchizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 323
Not applicableStudy completedNCT06043206
What this trial is testing

Bariatric Surgery in Patients With Schizophrenia

Who this might be right for
ObesitySchizophrenia
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 100
Not applicableStudy completedNCT00716755
What this trial is testing

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Centre for Addiction and Mental Health 45
Not applicableUnknownNCT02986490
What this trial is testing

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
University Hospital, Montpellier 100
Not applicableWithdrawnNCT05870384
What this trial is testing

Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia

Who this might be right for
Interpersonal PsychotherapyFamily Caregivers
Abant Izzet Baysal University
Post-approval studies (Phase 4)Study completedNCT01109147
What this trial is testing

Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients

Who this might be right for
Schizophrenia, Undifferentiated Type
Qualissima 67
Large-scale testing (Phase 3)Study completedNCT01625897
What this trial is testing

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 125
Next Page